Search research articles
Contact Us
Filters
Showing results (1-10 of 106) with videos related to
Page
of 11
Sort By:
Current Oncology (Toronto, Ont.)
|
May 26, 2023
The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. <i>Curr. Oncol.</i> 2022, <i>29</i>, 9891-9895
Maureen Trudeau, Brent Fraser
Breast Cancer Research and Treatment
|
May 29, 2007
Gemcitabine in the management of metastatic breast cancer: a systematic review
Susan Dent, Hans Messersmith, Maureen Trudeau
American Journal of Clinical Oncology
|
June 11, 2003
Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen
George Dranitsaris, Shailendra Verma, Maureen Trudeau
Journal of Oncology Practice
|
November 21, 2013
Evaluating an oncology systemic therapy computerized physician order entry system using international guidelines
Sonal Gandhi, Ivan Tyono, Mark Pasetka, et al.
Cancer
|
June 27, 2007
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
Nancy A Risebrough, Shailendra Verma, Maureen Trudeau, et al.
Clinical Breast Cancer
|
August 21, 2018
Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Jacques Raphael, Alex Kiss, Sharon Nofech-Mozes, et al.
Discovery Medicine
|
August 14, 2010
Radiation for early breast cancer: Is less more?
Anthony Fyles, Lee Manchul, David McCready, et al.
Chronobiology International
|
April 22, 2017
Chronobiological factors for compassion satisfaction and fatigue among ambulatory oncology caregivers
Daniela Bellicoso, Maureen Trudeau, Margaret I Fitch, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
Using the Edmonton Symptom Assessment System (ESAS) to Describe Symptom Burden Associated with Breast Cancer and Related Treatments: A Cross-Sectional Study
Sofia Torres, Maureen Trudeau, Geoffrey Liu, et al.
Journal of Patient-Reported Outcomes
|
March 21, 2026
Health-related quality of life in breast cancer measured with EQ-5D-5L
Sofia Torres, Maureen Trudeau, Geoffrey Liu, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 106) with videos related to
Sort By:
Page
of 11
Current Oncology (Toronto, Ont.)
|
May 26, 2023
The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. <i>Curr. Oncol.</i> 2022, <i>29</i>, 9891-9895
Maureen Trudeau, Brent Fraser
Breast Cancer Research and Treatment
|
May 29, 2007
Gemcitabine in the management of metastatic breast cancer: a systematic review
Susan Dent, Hans Messersmith, Maureen Trudeau
American Journal of Clinical Oncology
|
June 11, 2003
Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen
George Dranitsaris, Shailendra Verma, Maureen Trudeau
Journal of Oncology Practice
|
November 21, 2013
Evaluating an oncology systemic therapy computerized physician order entry system using international guidelines
Sonal Gandhi, Ivan Tyono, Mark Pasetka, et al.
Cancer
|
June 27, 2007
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
Nancy A Risebrough, Shailendra Verma, Maureen Trudeau, et al.
Clinical Breast Cancer
|
August 21, 2018
Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Jacques Raphael, Alex Kiss, Sharon Nofech-Mozes, et al.
Discovery Medicine
|
August 14, 2010
Radiation for early breast cancer: Is less more?
Anthony Fyles, Lee Manchul, David McCready, et al.
Chronobiology International
|
April 22, 2017
Chronobiological factors for compassion satisfaction and fatigue among ambulatory oncology caregivers
Daniela Bellicoso, Maureen Trudeau, Margaret I Fitch, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
Using the Edmonton Symptom Assessment System (ESAS) to Describe Symptom Burden Associated with Breast Cancer and Related Treatments: A Cross-Sectional Study
Sofia Torres, Maureen Trudeau, Geoffrey Liu, et al.
Journal of Patient-Reported Outcomes
|
March 21, 2026
Health-related quality of life in breast cancer measured with EQ-5D-5L
Sofia Torres, Maureen Trudeau, Geoffrey Liu, et al.
Page
of 11